<DOC>
	<DOC>NCT02955537</DOC>
	<brief_summary>This study seeks to evaluate a multicomponent mobile intervention to change multiple hypertension-related health behaviors in African Americans with uncontrolled hypertension. Half of the participants will receive a mobile intervention designed to improve physical activity, sodium intake, and medication adherence. The other half will receive usual care.</brief_summary>
	<brief_title>MI-BP: mHealth to Improve Blood Pressure Control in Hypertensive African Americans</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>African American Hypertensive Owning a compatible smartphone Presenting to the Detroit Medical Center with, but not necessarily for, uncontrolled blood pressure (systolic blood pressure â‰¥ 160 mm Hg at triage and on repeat measurement using the BpTRU device No selfreported prior history of hypertension No hypertension diagnosis documented in their medical record NonEnglish speaking Presenting with an acute illness necessitating immediate medical intervention Presenting with an admission to the hospital Pregnant (as determined by a dip test at screening), or selfreport during trial. Having the following serious comorbidities or confounders due to the fact that they may make blood pressure control difficult or necessitate frequent Emergency Department use or hospitalization: Previous diagnosis of resistant hypertension (or current use of 3 or more maximally dosed antihypertensive agents without achievement of blood pressure control) Steroid dependent asthma or emphysema Cirrhosis or hepatic failure Chronic heart failure (any stage) Previous diagnosis of acute myocardial infarction, angina (stable or unstable), or known coronary artery disease Previous diagnosis of cerebrovascular disease (including transient ischemic attack or stroke) Known valvular heart disease Stage IV or V chronic kidney disease Cancer (terminal or undergoing active chemotherapeutic or radiation therapy) Patients with other serious medical conditions that may affect their ability to selfmonitor blood pressure (such a dementia) Having a history of alcohol or drug abuse as determined by the CAGEAID questionnaire (excluded if 2 or more) Week 0 measurement of systolic blood pressure &lt; 140 mm Hg using the BpTRU device</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>mHealth</keyword>
</DOC>